nCounter(®) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA).

  title={nCounter(®) PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA).},
  author={Alessandra Cesano},
  journal={Journal for immunotherapy of cancer},
The nCounter PanCancer Immune Profiling Panel is a unique 770-plex gene expression panel to measure the human immune response in both solid and liquid cancer types. The panel measures many features of the immune response to facilitate rapid development of clinical actionable gene expression profiles in the context of cancer immunotherapy. The assay is run on the nCounter Analysis System (Nanostring Technologies, Inc.), an automated system which received 510(k) clearance from the FDA for use… CONTINUE READING
Highly Cited
This paper has 38 citations. REVIEW CITATIONS

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 16 extracted citations


Publications referenced by this paper.
Showing 1-4 of 4 references

Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD1, PD-L1 and CTLA-4

L Liu, PA Mayes, +6 authors Trametinib
Clin Cancer Res. 2015;21(7):1639–51. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color figure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at Cesano Journal for ImmunoTherapy of Cancer • 2015

Similar Papers

Loading similar papers…